CCAR1 promotes chromatin loading of androgen receptor (AR) transcription complex by stabilizing the association between AR and GATA2

Nucleic Acids Research

Volumn 41, Issue 18, 2013, Pages 8526-8536

  Seo, Woo Young ^a,b   Jeong, Byong Chang ^c   Yu, Eun Ji ^a,b   Kim, Hwa Jin ^a,b   Kim, Seok Hyung ^a,c   Lim, Joung Eun ^b   Kwon, Ghee Young ^c   Lee, Hyun Moo ^c   Kim, Jeong Hoon ^a,b  

^a Sungkyunkwan University   (South Korea)

^b Samsung Medical Center   (South Korea)

^c Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; CELL CYCLE AND APOPTOSIS REGULATOR 1; PROSTATE SPECIFIC ANTIGEN; PROTEIN MED1; REGULATOR PROTEIN; RNA POLYMERASE II; TRANSCRIPTION FACTOR GATA 2; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING SITE; CANCER CELL; CANCER INHIBITION; CARCINOGENICITY; CELL INVASION; CELL MIGRATION; CHROMATIN LOADING; CONTROLLED STUDY; ENHANCER REGION; GENE INTERACTION; GENE TARGETING; GENETIC ASSOCIATION; GENETIC PARAMETERS; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VIVO STUDY; MALE; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROSTATE CANCER; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION; PROTEIN STABILITY; SIGNAL TRANSDUCTION; TRANSCRIPTION INITIATION;

APOPTOSIS REGULATORY PROTEINS; CARCINOGENESIS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELLS, CULTURED; CHROMATIN; DIHYDROTESTOSTERONE; ENHANCER ELEMENTS, GENETIC; GATA2 TRANSCRIPTION FACTOR; HUMANS; MALE; NUCLEAR RECEPTOR COACTIVATORS; PROMOTER REGIONS, GENETIC; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; TRANSCRIPTION, GENETIC;

EID: 84885925602     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkt644     Document Type: Article

References (37)

1. Heinlein, C.A. and Chang, C. (2004) Androgen receptor in prostate cancer. Endocrine Rev., 25, 276-308.
2. Ahmad, N. and Kumar, R. (2011) Steroid hormone receptors in cancer development: A target for cancer therapeutics. Cancer Lett., 300, 1-9.
3. Lupien, M. and Brown, M. (2009) Cistromics of hormone-dependent cancer. Endocrine Relat. Cancer, 16, 381-389.
4. Heemers, H.V. and Tindall, D.J. (2007) Androgen receptor (AR) coregulators: A diversity of functions converging on and regulating the AR transcriptional complex. Endocrine Rev., 28, 778-808.
5. Wang, Q., Li, W., Liu, X.S., Carroll, J.S., Janne, O.A., Keeton, E.K., Chinnaiyan, A.M., Pienta, K.J. and Brown, M. (2007) A hierarchical network of transcription factors governs androgen receptor-dependent prostate cancer growth. Mol. Cell, 27, 380-392.
6. Jia, L., Berman, B.P., Jariwala, U., Yan, X., Cogan, J.P., Walters, A., Chen, T., Buchanan, G., Frenkel, B. and Coetzee, G.A. (2008) Genomic androgen receptor-occupied regions with different functions, defined by histone acetylation, coregulators and transcriptional capacity. PloS One, 3, e3645.
7. Wang, Q., Carroll, J.S. and Brown, M. (2005) Spatial and temporal recruitment of androgen receptor and its coactivators involves chromosomal looping and polymerase tracking. Mol. Cell, 19, 631-642.
8. Kim, J.H., Yang, C.K., Heo, K., Roeder, R.G., An, W. and Stallcup, M.R. (2008) CCAR1, a key regulator of mediator complex recruitment to nuclear receptor transcription complexes. Mol. Cell, 31, 510-519.
9. Fu, J., Jiang, J., Li, J., Wang, S., Shi, G., Feng, Q., White, E., Qin, J. and Wong, J. (2009) Deleted in breast cancer 1, a novel androgen receptor (AR) coactivator that promotes AR DNA-binding activity. J. Biol. Chem., 284, 6832-6840.
10. Yu, E.J., Kim, S.H., Heo, K., Ou, C.Y., Stallcup, M.R. and Kim, J.H. (2011) Reciprocal roles of DBC1 and SIRT1 in regulating estrogen receptor a activity and co-activator synergy. Nucleic Acids Res., 39, 6932-6943.
11. Kim, J.H., Li, H. and Stallcup, M.R. (2003) CoCoA, a nuclear receptor coactivator which acts through an N-terminal activation domain of p160 coactivators. Mol. Cell, 12, 1537-1549.
12. Hagege, H., Klous, P., Braem, C., Splinter, E., Dekker, J., Cathala, G., de Laat, W. and Forne, T. (2007) Quantitative analysis of chromosome conformation capture assays (3C-qPCR). Nat. Protoc., 2, 1722-1733.
13. Simon, J.M., Giresi, P.G., Davis, I.J. and Lieb, J.D. (2012) Using formaldehyde-assisted isolation of regulatory elements (FAIRE) to isolate active regulatory DNA. Nat. Protoc., 7, 256-267.
14. Kang, Z., Pirskanen, A., Janne, O.A. and Palvimo, J.J. (2002) Involvement of proteasome in the dynamic assembly of the androgen receptor transcription complex. J. Biol. Chem., 277, 48366-48371.
15. Kang, Z., Janne, O.A. and Palvimo, J.J. (2004) Coregulator recruitment and histone modifications in transcriptional regulation by the androgen receptor. Mol. Endocrinol., 18, 2633-2648.
16. Bao, B.Y., Chuang, B.F., Wang, Q., Sartor, O., Balk, S.P., Brown, M., Kantoff, P.W. and Lee, G.S. (2008) Androgen receptor mediates the expression of UDP-glucuronosyltransferase 2 B15 and B17 genes. Prostate, 68, 839-848.
17. Andreu-Vieyra, C., Lai, J., Berman, B.P., Frenkel, B., Jia, L., Jones, P.A. and Coetzee, G.A. (2011) Dynamic nucleosomedepleted regions at androgen receptor enhancers in the absence of ligand in prostate cancer cells. Mol. Cell. Biol., 31, 4648-4662.
18. Bohm, M., Locke, W.J., Sutherland, R.L., Kench, J.G. and Henshall, S.M. (2009) A role for GATA-2 in transition to an aggressive phenotype in prostate cancer through modulation of key androgen-regulated genes. Oncogene, 28, 3847-3856.
19. Makkonen, H., Kauhanen, M., Paakinaho, V., Jaaskelainen, T. and Palvimo, J.J. (2009) Long-range activation of FKBP51 transcription by the androgen receptor via distal intronic enhancers. Nucleic Acids Res., 37, 4135-4148.
20. Gupta, P., Park, S.W., Farooqui, M. and Wei, L.N. (2007) Orphan nuclear receptor TR2, a mediator of preadipocyte proliferation, is differentially regulated by RA through exchange of coactivator PCAF with corepressor RIP140 on a platform molecule GRIP1. Nucleic Acids Res., 35, 2269-2282.
21. Chinenov, Y., Sacta, M.A., Cruz, A.R. and Rogatsky, I. (2008) GRIP1-associated SET-domain methyltransferase in glucocorticoid receptor target gene expression. Proc. Natl Acad. Sci. USA, 105, 20185-20190.
22. Purcell, D.J., Jeong, K.W., Bittencourt, D., Gerke, D.S. and Stallcup, M.R. (2011) A distinct mechanism for coactivator versus corepressor function by histone methyltransferase G9a in transcriptional regulation. J. Biol. Chem., 286, 41963-41971.
23. Bittencourt, D., Wu, D.Y., Jeong, K.W., Gerke, D.S., Herviou, L., Ianculescu, I., Chodankar, R., Siegmund, K.D. and Stallcup, M.R. (2012) G9a functions as a molecular scaffold for assembly of transcriptional coactivators on a subset of glucocorticoid receptor target genes. Proc. Natl Acad. Sci. USA, 109, 19673-19678.
24. Zhang, L.J., Liu, X., Gafken, P.R., Kioussi, C. and Leid, M. (2009) A chicken ovalbumin upstream promoter transcription factor I (COUP-TFI) complex represses expression of the gene encoding tumor necrosis factor alpha-induced protein 8 (TNFAIP8). J. Biol. Chem., 284, 6156-6168.
25. Tsai, Y.C., Greco, T.M., Boonmee, A., Miteva, Y. and Cristea, I.M. (2012) Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription. Mol. Cell. Proteomics, 11, 60-76.
26. Barber, M.F., Michishita-Kioi, E., Xi, Y., Tasselli, L., Kioi, M., Moqtaderi, Z., Tennen, R.I., Paredes, S., Young, N.L., Chen, K. et al. (2012) SIRT7 links H3K18 deacetylation to maintenance of oncogenic transformation. Nature, 487, 114-118.
27. Sharma, N.L., Massie, C.E., Ramos-Montoya, A., Zecchini, V., Scott, H.E., Lamb, A.D., MacArthur, S., Stark, R., Warren, A.Y., Mills, I.G. et al. (2013) The androgen receptor induces a distinct transcriptional program in castration-resistant prostate cancer in man. Cancer Cell, 23, 35-47.
28. Wang, Q., Li, W., Zhang, Y., Yuan, X., Xu, K., Yu, J., Chen, Z., Beroukhim, R., Wang, H., Lupien, M. et al. (2009) Androgen receptor regulates a distinct transcription program in androgenindependent prostate cancer. Cell, 138, 245-256.
29. Zhou, H.J., Yan, J., Luo, W., Ayala, G., Lin, S.H., Erdem, H., Ittmann, M., Tsai, S.Y. and Tsai, M.J. (2005) SRC-3 is required for prostate cancer cell proliferation and survival. Cancer Res., 65, 7976-7983.
30. Chen, Z., Zhang, C., Wu, D., Chen, H., Rorick, A., Zhang, X. and Wang, Q. (2011) Phospho-MED1-enhanced UBE2C locus looping drives castration-resistant prostate cancer growth. EMBO J., 30, 2405-2419.
31. Kim, S.H., Kim, J.H., Yu, E.J., Lee, K.W. and Park, C.K. (2012) The overexpression of DBC1 in esophageal squamous cell carcinoma correlates with poor prognosis. Histol Histopathol., 27, 49-58.
32. Lee, D.Y., Northrop, J.P., Kuo, M.H. and Stallcup, M.R. (2006) Histone H3 lysine 9 methyltransferase G9a is a transcriptional coactivator for nuclear receptors. J. Biol. Chem., 281, 8476-8485.
33. Ianculescu, I., Wu, D.Y., Siegmund, K.D. and Stallcup, M.R. (2012) Selective roles for cAMP response element-binding protein binding protein and p300 protein as coregulators for androgenregulated gene expression in advanced prostate cancer cells. J. Biol. Chem., 287, 4000-4013.
34. Arredouani, M.S., Lu, B., Bhasin, M., Eljanne, M., Yue, W., Mosquera, J.M., Bubley, G.J., Li, V., Rubin, M.A., Libermann, T.A. et al. (2009) Identification of the transcription factor singleminded homologue 2 as a potential biomarker and immunotherapy target in prostate cancer. Clin. Cancer Res., 15, 5794-5802.
35. Grasso, C.S., Wu, Y.M., Robinson, D.R., Cao, X., Dhanasekaran, S.M., Khan, A.P., Quist, M.J., Jing, X., Lonigro, R.J., Brenner, J.C. et al. (2012) The mutational landscape of lethal castration-resistant prostate cancer. Nature, 487, 239-243.
36. Vanaja, D.K., Cheville, J.C., Iturria, S.J. and Young, C.Y. (2003) Transcriptional silencing of zinc finger protein 185 identified by expression profiling is associated with prostate cancer progression. Cancer Res., 63, 3877-3882.
37. Luo, J.H., Yu, Y.P., Cieply, K., Lin, F., Deflavia, P., Dhir, R., Finkelstein, S., Michalopoulos, G. and Becich, M. (2002) Gene expression analysis of prostate cancers. Mol. Carcinog., 33, 25-35.